Malisetty V. Swamy

1.5k total citations
20 papers, 1.3k citations indexed

About

Malisetty V. Swamy is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Malisetty V. Swamy has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Cancer Research. Recurrent topics in Malisetty V. Swamy's work include Inflammatory mediators and NSAID effects (7 papers), Cancer, Lipids, and Metabolism (6 papers) and Gastrointestinal motility and disorders (3 papers). Malisetty V. Swamy is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Cancer, Lipids, and Metabolism (6 papers) and Gastrointestinal motility and disorders (3 papers). Malisetty V. Swamy collaborates with scholars based in United States, India and Canada. Malisetty V. Swamy's co-authors include Chinthalapally V. Rao, Jagan M.R. Patlolla, Jayadev Raju, Bandaru S. Reddy, Wei Dai, Yuqiang Fang, Tongyi Liu, Radma Mahmood, Vernon E. Steele and Levy Kopelovich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and International Journal of Cancer.

In The Last Decade

Malisetty V. Swamy

20 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Malisetty V. Swamy United States	15	719	340	328	267	176	20	1.3k
Kengo Matsunaga Japan	15	525 0.7×	233 0.7×	301 0.9×	110 0.4×	175 1.0×	27	1.1k
Jun Hee Lim South Korea	22	1.1k 1.5×	149 0.4×	240 0.7×	202 0.8×	200 1.1×	38	1.7k
Zhi Dai China	20	975 1.4×	275 0.8×	241 0.7×	370 1.4×	170 1.0×	59	1.9k
Iris J. Edwards United States	23	685 1.0×	287 0.8×	130 0.4×	648 2.4×	125 0.7×	32	1.7k
Chuan‐Ming Xie China	18	738 1.0×	98 0.3×	187 0.6×	185 0.7×	176 1.0×	42	1.3k
Shih-Lan Hsu Taiwan	23	810 1.1×	140 0.4×	241 0.7×	184 0.7×	246 1.4×	38	1.6k
Huanjie Shao China	17	862 1.2×	95 0.3×	180 0.5×	285 1.1×	165 0.9×	37	1.4k
Shizuo Odashima Japan	21	1.1k 1.6×	451 1.3×	370 1.1×	130 0.5×	71 0.4×	58	1.7k
Wei-Jiunn Lee Taiwan	24	999 1.4×	82 0.2×	311 0.9×	413 1.5×	173 1.0×	42	1.6k
Atsuko Deguchi Japan	22	810 1.1×	79 0.2×	340 1.0×	201 0.8×	163 0.9×	36	1.7k

Countries citing papers authored by Malisetty V. Swamy

Since Specialization

Citations

This map shows the geographic impact of Malisetty V. Swamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malisetty V. Swamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malisetty V. Swamy more than expected).

Fields of papers citing papers by Malisetty V. Swamy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malisetty V. Swamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malisetty V. Swamy. The network helps show where Malisetty V. Swamy may publish in the future.

Co-authorship network of co-authors of Malisetty V. Swamy

This figure shows the co-authorship network connecting the top 25 collaborators of Malisetty V. Swamy. A scholar is included among the top collaborators of Malisetty V. Swamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malisetty V. Swamy. Malisetty V. Swamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Swamy, Malisetty V., et al.. (2022). Evaluation of efficacy and safety of Bacillus coagulans SNZ 1969 supplementation for irritable bowel syndrome: a randomized, double-blind, placebo-controlled study. International Journal of Basic & Clinical Pharmacology. 11(6). 550–550. 1 indexed citations

Swamy, Malisetty V., et al.. (2022). Efficacy and Safety of Probiotic Bacillus coagulans-SNZ 1969 in Gastrointestinal Discomfort: A Randomized, Placebo-Controlled Study. International Journal of Health Sciences and Research. 12(3). 253–264. 2 indexed citations

Swamy, Malisetty V., et al.. (2019). A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort. International Journal of Colorectal Disease. 34(11). 1971–1978. 14 indexed citations

Janakiram, Naveena B., Malisetty V. Swamy, Jagan M.R. Patlolla, Suresh Guruswamy, & Chinthalapally V. Rao. (2010). Abstract 954: A selective iNOS inhibitor N6-iminoethyl-lysine tetrazoleamide (NILT), suppress invasive colonic cancers and improves preventive efficacy of low-dose COX-2 inhibitor, celecoxib in F344 rats. Cancer Research. 70(8_Supplement). 954–954. 1 indexed citations

Rao, Chinthalapally V., Vernon E. Steele, Malisetty V. Swamy, et al.. (2009). Inhibition of Azoxymethane-Induced Colorectal Cancer by CP-31398, a TP53 Modulator, Alone or in Combination with Low Doses of Celecoxib in Male F344 Rats. Cancer Research. 69(20). 8175–8182. 27 indexed citations

Swamy, Malisetty V., et al.. (2008). Prevention and Treatment of Pancreatic Cancer by Curcumin in Combination With Omega-3 Fatty Acids. Nutrition and Cancer. 60(sup1). 81–89. 73 indexed citations

Rao, Chinthalapally V., Malisetty V. Swamy, Jagan M.R. Patlolla, & Levy Kopelovich. (2008). Suppression of Familial Adenomatous Polyposis by CP-31398, a TP53 Modulator, in APCmin/+ Mice. Cancer Research. 68(18). 7670–7675. 33 indexed citations

Guruswamy, Suresh, Malisetty V. Swamy, Chang‐In Choi, Vernon E. Steele, & Chinthalapally V. Rao. (2007). S‐adenosyl L‐methionine inhibits azoxymethane‐induced colonic aberrant crypt foci in F344 rats and suppresses human colon cancer Caco‐2 cell growth in 3D culture. International Journal of Cancer. 122(1). 25–30. 32 indexed citations

Swamy, Malisetty V., Jagan M.R. Patlolla, Vernon E. Steele, et al.. (2006). Chemoprevention of Familial Adenomatous Polyposis by Low Doses of Atorvastatin and Celecoxib Given Individually and in Combination to APCMin Mice. Cancer Research. 66(14). 7370–7377. 113 indexed citations

10.

Patlolla, Jagan M.R., Jayadev Raju, Malisetty V. Swamy, & Chinthalapally V. Rao. (2006). β-Escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21waf1/cip1 in colon cancer cells. Molecular Cancer Therapeutics. 5(6). 1459–1466. 68 indexed citations

11.

Rao, Chinthalapally V., Malisetty V. Swamy, Tongyi Liu, et al.. (2005). Colonic tumorigenesis in BubR1 ^+/– Apc ^{Min /+} compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proceedings of the National Academy of Sciences. 102(12). 4365–4370. 135 indexed citations

12.

Raju, Jayadev, Jagan M.R. Patlolla, Malisetty V. Swamy, & Chinthalapally V. Rao. (2004). Colon cancer preventive effects of Trigonella foenum graecum (fenugreek) seed and its constituent diosgenin using in vitro and in vivo models.. Cancer Research. 64. 731–731. 3 indexed citations

13.

Raju, Jayadev, Malisetty V. Swamy, Indranie Cooma, et al.. (2004). Low doses of β‐carotene and lutein inhibit AOM‐induced rat colonic ACF formation but high doses augment ACF incidence. International Journal of Cancer. 113(5). 798–802. 28 indexed citations

14.

Dai, Wei, Qi Wang, Tongyi Liu, et al.. (2004). Slippage of Mitotic Arrest and Enhanced Tumor Development in Mice with BubR1 Haploinsufficiency. Cancer Research. 64(2). 440–445. 252 indexed citations

15.

Patlolla, Jagan M.R., Malisetty V. Swamy, Jayadev Raju, & Chinthalapally V. Rao. (2004). Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. Oncology Reports. 11(5). 957–63. 61 indexed citations

16.

Raju, Jayadev, Jagan M.R. Patlolla, Malisetty V. Swamy, & Chinthalapally V. Rao. (2004). Diosgenin, a Steroid Saponin of Trigonella foenum graecum (Fenugreek), Inhibits Azoxymethane-Induced Aberrant Crypt Foci Formation in F344 Rats and Induces Apoptosis in HT-29 Human Colon Cancer Cells. Cancer Epidemiology Biomarkers & Prevention. 13(8). 1392–1398. 234 indexed citations

17.

Swamy, Malisetty V., Indranie Cooma, Jagan M.R. Patlolla, et al.. (2004). Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: Novel strategies for colon cancer prevention and treatment. Molecular Cancer Therapeutics. 3(2). 215–221. 59 indexed citations

18.

Swamy, Malisetty V., Christopher R. Herzog, & Chinthalapally V. Rao. (2003). Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.. PubMed. 63(17). 5239–42. 79 indexed citations

19.

Swamy, Malisetty V., Indranie Cooma, Bandaru S. Reddy, & Chinthalapally V. Rao. (2002). Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: A novel approach in developing effective chemopreventive regimens. International Journal of Oncology. 20(4). 753–9. 49 indexed citations

20.

El‐Bayoumy, Karam, David R. Rose, Nick Papanikolaou, et al.. (2002). Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: Impact of an organoselenium compound on growth regulation. International Journal of Oncology. 20(3). 557–61. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact